首页 正文

Immunotherapy for Leiomyosarcoma: Current Status and Perspectives

{{output}}
Leiomyosarcoma (LMS), one of the soft-tissue sarcomas (STSs), has a relatively higher risk of distant metastasis. This has resulted in current first-line treatments still failing to deliver satisfactory outcomes, and the current treatment of LMS remains contro... ...